The study of signaling molecules in the body often leads to fascinating discoveries regarding how internal systems communicate. One such area of intense interest involves peptide YY, a 36-amino acid peptide encoded by the PYY gene. Since its initial isolation from porcine intestinal tissue in 1982, researchers have worked to map its interactions, specifically focusing on how it functions as a gut hormone peptide YY (PYY).
My personal interest in this field stems from a fascination with how these peptides influence physiological stability. By examining the peptide YY (PYY) receptors, we can better appreciate the intricate network that governs our internal biological environment.
The Architecture of Y Receptors
The receptor system associated with PYY is remarkably diverse. There are five Y receptors: Y1, Y2, Y4, Y5, and peptide yy neuropeptide Y2 receptor agonist Y6, which are G-protein-coupled receptors. These are expressed in various human tissues, including the brain and the gastrointestinal tract. While there are four r Neuropeptide Y receptors: how to get subtype selectivity - Frontiers eceptors in humans (hY1, hY2, hY4, hY5), the versatility of this system allows it to participate in a wide array of signaling pathways.
For instance, the Neuropeptide Y type 5 (NPY5) receptor is just one of the subtypes that help manage the signals sent throughout the body. When PYY administered directly into the brain binds to various Y receptors, it triggers a cascade of responses that demonstrate how tightly integrated these systems are.
Functional Dynamics: Appetite and Beyond
One of the most discussed aspects of this system is how it decreases appetite and makes people feel full after eating. Often referred to as the "ileal brake," peptide YY is secreted from the ileum and colon in response to nutrition. This process is a primary example of a peptide serving as a com by NT Nguyen·2025·Cited by 3—Additionally,PYY may improve insulin sensitivityby acting via Y1 and Y4 receptors in peripheral tissues such as the liver, adipose tissue, and islets, Read more municator between the gut and the brain.
In my exploration of these mechanisms, I have found it incredible that PYY has recently been found in the central nervous system. This presence suggests that its role extends far beyond simple digestion. For example:
* The Y1 receptor plays a role in functions such as regulating gastrointestinal movement and maintaining fluid balance within the body system.
* PYY3-36 is a selective agonist for the Y2 receptor, which has been studied for its specific affinity.
* PYY may improve insulin sensitivity by acting via Y1 and Y4 receptors in peripheral tissues such as the liver and adipose tissue.
Investigating Agonists and Selectivity
Much of the current research revolves around finding a potent neuropeptide Y2 receptor agonist. Because PYY is an agonist of the presynaptic Y2 receptor, it has become a central focus for those interested in the NPY/PYY receptor Y2.
It is also noteworthy that certain developments involve a neuropeptide Y1, and neuropeptide Y2 receptors combination, The role of peptide YY in appetite regulation and obesity - PMC - NIH often explored in the context of scientific investigations into peptide YY. Some researchers are even Peptide YY is a peptide thatis secreted from the ileum and colon in response to nutritionand reduces appetite and hence called “ileal brake.”Read more looking at how a compound being evaluated for the treatment of obesity might utilize these pathways to influence weight management, though these remain experimental.
Final Observations
Whether we are looking at the neuropeptide Y1, and neuropeptide Y2 receptors or the broader peptide YY (PYY) family, it is clear that these molecules play a crucial role in regulating various physiological processes. The study of these receptors of peptide YY - Ligands fers a window into the complex biological machinery that keeps our internal systems in balance.
As someone who reviews these developments, I am constantly impressed by how a single protein chain can have such prof by KS Chichura·2023·Cited by 21—A peptide triple agonist of GLP-1,neuropeptide Y1, and neuropeptide Y2 receptorspromotes glycemic control and weight loss. Kylie S. Chichura, Read more ound effects. The precision with which these receptors operate—and the potential for future discovery—remains one of the most compelling narratives in modern biochemistry.